Electrical impedance myography as a biomarker to assess ALS progression

References

• Cudkowicz ME, Katz J, Moore DH, O’Neill G, Glass JD, Mitsumoto H, . Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:259–65.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, . Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol. 2006;60: 22–31.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, . Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurol. 2007;6:1045–53.
   PubMed Web of Science ®Google Scholar
• Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, . Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:481–8.
   PubMed Web of Science ®Google Scholar
• Rutkove SB. Electrical Impedance Myography: Background, Current State, and Future Directions. Muscle Nerve. 2009; 40:936–46.
   PubMed Web of Science ®Google Scholar
• Tarulli A, Esper G, Lee K, Aaron R, Shiffman C, Rutkove S. Electrical impedance myography in the bedside assessment of inflammatory myopathy. Neurology. 2005;65:451–2.
   PubMed Web of Science ®Google Scholar
• Rutkove SB, Shefner JM, Gregas M, Butler H, Caracciolo J, Lin C, . Characterizing spinal muscular atrophy with electrical impedance myography. Muscle Nerve. 2010;42: 915–21.
   PubMed Web of Science ®Google Scholar
• Tarulli AW, Duggal N, Esper GJ, Garmirian LP, Fogerson PM, Lin CH, . Electrical impedance myography in the assessment of disuse atrophy. Arch Phys Med Rehabil. 2009; 90:1806–10.
   PubMedGoogle Scholar
• Rutkove SB, Zhang H, Schoenfeld DA, Raynor EM, Shefner JM, Cudkowicz ME, . Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials. Clin Neurophysiol. 2007;118:2413–8.
   PubMed Web of Science ®Google Scholar
• Wang LL, Spieker AJ, Li J, Rutkove SB. Electrical impedance myography for monitoring motor neuron loss in the SOD1-G93A amyotrophic lateral sclerosis rat. Clin Neurophysiol. 2011;122:2505–11.
   PubMed Web of Science ®Google Scholar
• Rutkove SB, Lee KS, Shiffman CA, Aaron R. Test-Retest Reproducibility of 50 kHz Linear-Electrical Impedance Myography. Clin Neurophys. 2006;117:1244–8.
   PubMed Web of Science ®Google Scholar
• Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, . Multipoint incremental motor unit number estimation as an outcome measure in ALS. Neurology. 2011;77:235–41.
   PubMed Web of Science ®Google Scholar
• Li J, Fogerson PM, Rutkove SB. Measuring the multifrequency electrical impedance of the mouse gastrocnemius muscle using a tetrapolar technique. International Conference on Electrical Impedance; April, 2010; Gainesville, FL 2010 http://bioimpedance.bme.ufl.edu/icebi/2509_Rutkove.pdf.
   Google Scholar
• Lungu C, Tarulli AW, Tarsy D, Mongiovi P, van der Horst VG, Rutkove SB. Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment. Clin Neurophysiol. 2011;122:1027–31.
   PubMedGoogle Scholar
• Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571–5.
   PubMed Web of Science ®Google Scholar
• Rutkove S, Partida R, Esper G, Aaron R, Shiffman C. Electrode position and size in electrical impedance myography. Clin Neurophys. 2005;116:290–9.
   PubMed Web of Science ®Google Scholar
• Jaffrin MY. Body composition determination by bioimpedance: an update. Curr Opin Clin Nutr Metab Care. 2009; 12:482–6.
   PubMed Web of Science ®Google Scholar
• Desport JC, Marin B, Funalot B, Preux PM, Couratier P. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2008;9:273–8.
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, . A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 2003;61:456–64.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Miller EG. Aymptotic test statistics for coefficient of variation. Comm in stats: theory and methods. 1991;20:3351–63.
   Web of Science ®Google Scholar
• Zhang Y, Schuff N, Woolley SC, Chiang GC, Boreta L, Laxamana J, . Progression of white matter degeneration in amyotrophic lateral sclerosis: a diffusion tensor imaging study. Amyotroph Lateral Scler. 2011;12:421–9.
   PubMed Web of Science ®Google Scholar
• Pastula DM, Moore DH, Bedlack RS. Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2010:CD005225.
   PubMedGoogle Scholar
• Chio A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, . ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology. 2011;77: 1432–7.
   PubMed Web of Science ®Google Scholar
• Ogunnika OT, Rutkove SB, Ma H, Fogerson PM, Scharfstein M, Cooper RC, . A portable system for the assessment of neuromuscular diseases with electrical impedance myography. J Med Eng Technol. 2010;35:377–85.
   Google Scholar